{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:01:59Z","timestamp":1790226119253,"version":"4.1.0"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"\n Introduction<\/jats:title>\n Anti-M\u00fcllerian hormone (AMH) is widely used as a marker of ovarian reserve and is also incorporated into the diagnostic assessment of polyendocrine metabolic ovarian syndrome (PMOS). Although PMOS is strongly associated with metabolic dysfunction and abnormal adipose tissue distribution, the relationship between AMH concentrations and adiposity, and especially visceral adiposity remains unclear. This study aimed to evaluate the association between serum AMH levels and selected adiposity and metabolic markers in women with PMOS.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n This cross-sectional study included 1147 women with newly diagnosed PMOS. Serum AMH, sex hormone-binding globulin (SHBG), glucose, insulin, lipid profile, and other hormonal parameters were assessed. Anthropometric measurements included body mass index (BMI), waist and hip circumference, and waist-to-hip ratio (WHR). Percent body fat (PBF) and visceral fat area (VFA) were assessed using bioelectrical impedance analysis. The lipid accumulation product (LAP), cardiometabolic index (CMI), and homeostatic model assessment of insulin resistance (HOMA-IR) were calculated.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n AMH concentrations showed very weak inverse correlations with adiposity markers, WHR (\n r<\/jats:italic>\n \u00a0=\u00a0-.05,\n p<\/jats:italic>\n \u00a0&lt;.05), VFA (\n r<\/jats:italic>\n \u00a0=\u00a0-.1,\n p<\/jats:italic>\n \u00a0&lt;.05), CMI (\n r<\/jats:italic>\n \u00a0=\u00a0-.06,\n p<\/jats:italic>\n \u00a0&lt;.05), and LAP (\n r<\/jats:italic>\n \u00a0=\u00a0-.1,\n p<\/jats:italic>\n \u00a0&lt;.05), while a positive correlation was observed between AMH and SHBG levels (\n r<\/jats:italic>\n \u00a0= .07,\n p<\/jats:italic>\n \u00a0&lt;.05). In contrast, LAP was moderately or strongly positively correlated with fasting insulin (\n r<\/jats:italic>\n \u00a0= .67,\n p<\/jats:italic>\n \u00a0&lt;.05), HOMA-IR (\n r<\/jats:italic>\n \u00a0= .67,\n p<\/jats:italic>\n \u00a0&lt;.05), PBF (\n r<\/jats:italic>\n \u00a0= .76,\n p<\/jats:italic>\n \u00a0&lt;.05), and anthropometric measures, and negatively correlated with HDL cholesterol (\n r<\/jats:italic>\n \u00a0=\u00a0-.64,\n p<\/jats:italic>\n \u00a0&lt;.05) and SHBG (\n r<\/jats:italic>\n \u00a0=\u00a0-.62,\n p<\/jats:italic>\n \u00a0&lt;.05). Principal component analysis (PCA) identified two major metabolic dimensions, predominantly reflecting triglyceride and cholesterol-related variation, which together explained 68.8% of the total variance. AMH showed no correlation with any of them.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n In women with PMOS, serum AMH concentrations are negligibly associated with adiposity markers despite strong relationships between these markers and metabolic dysfunction. Therefore, AMH levels should be interpreted primarily in the context of age and reproductive characteristics rather than as a direct marker of visceral adiposity or metabolic risk.<\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fendo.2026.1975667","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:39:58Z","timestamp":1790224798000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Anti-M\u00fcllerian hormone in relation to adiposity and metabolic indices in polyendocrine metabolic ovarian syndrome"],"prefix":"10.3389","volume":"17","author":[{"given":"Karolina","family":"Kowalczyk","sequence":"first","affiliation":[{"name":"Chair and Department of Gynecology, Obstetrics and Oncological Gynecology, Medical University of Silesia","place":["Katowice, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominika","family":"Ga\u0142czy\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Endocrinological Gynecology, Faculty of Medical Sciences, Medical University of Silesia","place":["Katowice, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Herman","sequence":"additional","affiliation":[{"name":"Chair and Department of Gynecology, Obstetrics and Oncological Gynecology, Medical University of Silesia","place":["Katowice, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Czy\u017c","sequence":"additional","affiliation":[{"name":"Chair and Department of Gynecology, Obstetrics and Oncological Gynecology, Medical University of Silesia","place":["Katowice, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariusz","family":"Kowalczyk","sequence":"additional","affiliation":[{"name":"Department of Anatomy, School of Medicine in Opole, University of Opole","place":["Opole, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Drosdzol-Cop","sequence":"additional","affiliation":[{"name":"Chair and Department of Gynecology, Obstetrics and Oncological Gynecology, Medical University of Silesia","place":["Katowice, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Franik","sequence":"additional","affiliation":[{"name":"Department of Endocrinological Gynecology, Faculty of Medical Sciences, Medical University of Silesia","place":["Katowice, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(26)00717-8","article-title":"Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process","volume":"407","author":"Teede","year":"2026","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12041454","article-title":"Polycystic ovary syndrome: etiology, current management, and future therapeutics","volume":"12","author":"Singh","year":"2023","journal-title":"J Clin Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-8-41","article-title":"Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan","volume":"8","author":"Teede","year":"2010","journal-title":"BMC Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"108","author":"Teede","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.5603\/EP.a2016.0065","article-title":"Anti-M\u00fcllerian hormone and polycystic ovary syndrome","author":"\u0141ebkowska","year":"","journal-title":"Endokrynol Pol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222212507","article-title":"Anti-M\u00fcllerian hormone in pathogenesis, diagnostic and treatment of PCOS","volume":"22","author":"Rudnicka","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S329108","article-title":"Analysis of endocrine and metabolic indexes in non-obese patients with polycystic ovary syndrome and its compare with obese patients","volume":"14","author":"Shi","year":"2021","journal-title":"Diabetes Metab Syndr Obes Targets Ther"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2014.920004","article-title":"Anti-Mullerian hormone and insulin resistance in polycystic ovary syndrome","volume":"30","author":"Fonseca","year":"2014","journal-title":"Gynecol Endocrinol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.fertnstert.2014.03.032","article-title":"Age-specific serum antim\u00fcllerian hormone levels in women with and without polycystic ovary syndrome","volume":"102","author":"Cui","year":"2014","journal-title":"Fertil Steril"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S393594","article-title":"The relationship between insulin resistance and obesity and serum anti-mullerian hormone level in Chinese women with polycystic ovary syndrome: a retrospective, single-center cohort study","volume":"15","author":"Zhao","year":"2023","journal-title":"Int J Womens Health"},{"key":"B11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12958-023-01064-y","article-title":"The reference value of anti-m\u00fcllerian hormone to diagnose polycystic ovary syndrome is inversely associated with BMI: a retrospective study","volume":"21","author":"Zhang","year":"2023","journal-title":"Reprod Biol Endocrinol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2011.06.006","article-title":"Is the plasma anti-m\u00fcllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome","volume":"158","author":"Ska\u0142ba","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.5653\/cerm.2013.40.3.135","article-title":"Can high serum anti-m\u00fcllerian hormone levels predict the phenotypes of polycystic ovary syndrome (PCOS) and metabolic disturbances in PCOS patients","volume":"40","author":"Hwang","year":"2013","journal-title":"Clin Exp Reprod Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2016.10.009","article-title":"Antim\u00fcllerian hormone levels and cardiometabolic risk in young women with polycystic ovary syndrome","volume":"107","author":"Feldman","year":"2017","journal-title":"Fertil Steril"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae473","article-title":"Is it time to define obesity by body composition and not solely body mass index","volume":"110","author":"Lucas","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcad.2013.10.003","article-title":"The concept of normal weight obesity","volume":"56","author":"Oliveros","year":"2014","journal-title":"Prog Cardiovasc Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2014.07.017","article-title":"Visceral adiposity and the risk of metabolic syndrome across body mass index","volume":"7","author":"Shah","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"B18","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1186\/s12879-023-08833-5","article-title":"Visceral fat area measured by electrical bioimpedance as an aggravating factor of COVID-19: a study on body composition","volume":"23","author":"Carvalho","year":"2023","journal-title":"BMC Infect Dis"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/s140610895","article-title":"The theory and fundamentals of bioimpedance analysis in clinical status monitoring and diagnosis of diseases","volume":"14","author":"Khalil","year":"2014","journal-title":"Sensors"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41430-023-01310-x","article-title":"The bioelectrical impedance analysis (BIA) international database: aims, scope, and call for data","volume":"77","author":"Silva","year":"2023","journal-title":"Eur J Clin Nutr"},{"key":"B21","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12902-024-01783-2","article-title":"Body composition analysis in women with polycystic ovary syndrome: a cross-sectional study from the Tehran Lipid and Glucose Study (TLGS)","volume":"24","author":"Zakeri","year":"2024","journal-title":"BMC Endocr Disord"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1085656","article-title":"Relationship between body composition, insulin resistance, and hormonal profiles in women with polycystic ovary syndrome","volume":"13","author":"Zhang","year":"2023","journal-title":"Front Endocrinol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtumed.2016.11.005","article-title":"Anthropometric and body composition analysis of infertile women with polycystic ovary syndrome","volume":"12","author":"Chitme","year":"2017","journal-title":"J Taibah Univ Med Sci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0200465","article-title":"Comparison of body composition assessment by DXA and BIA according to the body mass index: a retrospective study on 3655 measures","volume":"13","author":"Achamrah","year":"2018","journal-title":"PloS One"},{"key":"B25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12944-023-01802-6","article-title":"Lipid accumulation product (LAP) index for the diagnosis of nonalcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis","volume":"22","author":"Ebrahimi","year":"2023","journal-title":"Lipids Health Dis"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2261-5-26","article-title":"The \u201clipid accumulation product\u201d performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison","volume":"5","author":"Kahn","year":"2005","journal-title":"BMC Cardiovasc Disord"},{"key":"B27","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12944-018-0886-2","article-title":"Estimate of prevalent diabetes from cardiometabolic index in general Chinese population: a community-based study","volume":"17","author":"Shi","year":"2018","journal-title":"Lipids Health Dis"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(81)90746-8","article-title":"Hirsutism: implications, etiology, and management","volume":"140","author":"Hatch","year":"1981","journal-title":"Am J Obstet Gynecol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","article-title":"Criteria, prevalence, and phenotypes of polycystic ovary syndrome","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil Steril"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13102843","article-title":"The lipid accumulation product index (LAP) and the cardiometabolic index (CMI) are useful for predicting the presence and severity of metabolic syndrome in adult patients with obesity","volume":"13","author":"Tamini","year":"2024","journal-title":"J Clin Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/edm2.70078","article-title":"Lipid accumulation product index as a marker of metabolic syndrome in women with polycystic ovary syndrome: a systematic review and meta\u2010analysis","volume":"8","author":"Seyedi","year":"2025","journal-title":"Endocrinol Diabetes Metab"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/cob.12559","article-title":"The relationship between anti\u2010m\u00fcllerian hormone, body mass index and weight loss: a review of the literature","volume":"12","author":"Kloos","year":"2022","journal-title":"Clin Obes"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1530\/EC-21-0243","article-title":"Anti-m\u00fcllerian hormone was independently associated with central obesity but not with general obesity in women with PCOS","volume":"11","author":"Zeng","year":"2022","journal-title":"Endocr Connect"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2024.04.012","article-title":"Contributions of white adipose tissue to energy requirements for female reproduction","volume":"35","author":"Anaya","year":"2024","journal-title":"Trends Endocrinol Metab"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/nu16234149","article-title":"The relationship between body composition parameters and the intake of selected nutrients, and serum anti-m\u00fcllerian hormone (AMH) levels in the context of ovulatory infertility","volume":"16","author":"Skowro\u0144ska","year":"2024","journal-title":"Nutrients"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s43032-024-01561-4","article-title":"The relationship between anti-m\u00fcllerian hormone and body composition components in patients with polycystic ovary syndrome of reproductive age","volume":"31","author":"Li","year":"2024","journal-title":"Reprod Sci"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.5935\/abc.20180054","article-title":"Is lipid accumulation product associated with an atherogenic lipoprotein profile in Brazilian subjects","author":"Cartolano","year":"2018","journal-title":"Arq Bras Cardiol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/medicina61061012","article-title":"Investigation of inflammatory markers in patients with polycystic ovary syndrome receiving and not receiving metformin treatment","volume":"61","author":"Bulu","year":"2025","journal-title":"Med (Kaunas)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-022-01091-0","article-title":"Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment","volume":"16","author":"Zhao","year":"2023","journal-title":"J Ovarian Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjog.2019.05.003","article-title":"Dyslipidemia involvement in the development of polycystic ovary syndrome","volume":"58","author":"Liu","year":"2019","journal-title":"Taiwan J Obstet Gynecol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-2586","article-title":"Hyperandrogenism accompanies increased intra-abdominal fat storage in normal weight polycystic ovary syndrome women","volume":"101","author":"Dumesic","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.16047","article-title":"Correlation of homeostatic model assessment-insulin resistance, anti-mullerian hormone, and BMI in the characterization of polycystic ovary syndrome","author":"Bahadur","year":"2021","journal-title":"Cureus"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dep072","article-title":"Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome","volume":"24","author":"Wiltgen","year":"2009","journal-title":"Hum Reprod"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2026.1709946","article-title":"The accuracy of lipid accumulation product to predict metabolic syndrome in PCOS: a meta-analysis and comparative analysis with other indicators","volume":"17","author":"Liu","year":"2026","journal-title":"Front Endocrinol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2147\/IJWH.S344542","article-title":"Effect of sex hormone-binding globulin on polycystic ovary syndrome: mechanisms, manifestations, genetics, and treatment","volume":"14","author":"Xing","year":"2022","journal-title":"Int J Womens Health"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1975667\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:40:05Z","timestamp":1790224805000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1975667\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":46,"alternative-id":["10.3389\/fendo.2026.1975667"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1975667","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"article-number":"1975667"}}